… is the assertion that "continuous" inhaled beta‐agonist therapy is more efficacious for
acute asthma than the conventional (intermittent) method of beta‐agonist delivery (eg, 2.5 mg …

… with inhaled beta-agonists were reviewed, … of beta-agonist use in acute asthma such
as beta-agonists versus other bronchodilators, aerosol delivery, and intravenous beta-agonists …

… (4) beta‐agonist OR betaagonist OR beta agonist OR bronchodilat* OR adrenaline OR
albuterol OR bricanyl OR epinephrine OR isoprenaline OR isoproterenol OR hexoprenaline OR …

… support the use of IV beta 2 ‐agonists in patients with severe acute asthma. These drugs
should … investigating the addition of intravenous beta agonists to inhaled beta agonist therapy. …

… A computerized search was conducted to identify literature on the topic of continuous vs
intermittent nebulization with β-agonists in adult patients with acute asthma. We searched for …

… work clarify the use of IV β 2 -agonists in the treatment of severe acute asthma. The use of
IV β 2 -agonists compared to inhaled β 2 -agonists or IV methylxanthines did not lead to any …

… detailed algorithms for pathways of management in acute asthma exacerbations, it is not the
… of large-volume spacers and the role of intravenous β 2 -agonists in acute severe asthma. …

… of β 2 agonist-mediated response. The role that the β 2 AR haplotype plays in regulating
response to β 2 agonist … In the near future, we may be prescribing β 2 agonist to control asthma …

… 67 hospital doctors regularly used intravenous 13 agonist. 9 We believe that intravenous 13
agonists have a place in treating some severely asthmatic patients. It must be remembered, …

… Purpose: To review the literature to determine whether inhaled ipratropium bromide provides
additive benefits to adults with acute asthma who are being treated with beta-agonists in an …